Pharmacokinetics of repaglinide in healthy caucasian and Japanese subjects.

This publication has 18 references indexed in Scilit:

• Clinical Pharmacokinetics and Pharmacodynamics of Repaglinide
  Clinical Pharmacokinetics, 2002
• CYP3A activity in European American and Japanese men using midazolam as an in vivo probe
  Clinical Pharmacology & Therapeutics, 2001
• Molecular Basis of Ethnic Differences in Drug Disposition and Response
  Annual Review of Pharmacology and Toxicology, 2001
• Ethnic Differences in Drug Metabolism
  cclm, 2000
• Increased prandial insulin secretion after administration of a single preprandial oral dose of repaglinide in patients with type 2 diabetes.
  Diabetes Care, 2000
• Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations
  Xenobiotica, 2000
• Repaglinide in Type 2 Diabetes: A 24-Week, Fixed-Dose Efficacy and Safety Study
  The Journal of Clinical Pharmacology, 2000
• Rapid-acting insulin secretagogues: a clinical need?
  Experimental and Clinical Endocrinology & Diabetes, 1999
• Effect of CYP2C Polymorphisms on the Pharmacokinetics of Phenytoin in Japanese Patients with Epilepsy.
  Biological & Pharmaceutical Bulletin, 1996
• Factors affecting the absolute bioavailability of nifedipine.
  British Journal of Clinical Pharmacology, 1995